Healthcare -
Biotechnology - NASDAQ - US
$ 0.469
0.428 %
$ 3.26 M
Market Cap
-0.11
P/E
HEPA - STOCK-BASED COMPENSATION
Stock-based Compensation HEPA - Hepion Pharmaceuticals, Inc.
1.34 M
LAST VALUE
-46.42%
2 YEAR CAGR
41.71%
5 YEAR CAGR
21.25%
10 YEAR CAGR